朕天下娛樂城
Invest in 朕天下娛樂城
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
PPLPHARMA ?NSE
Piramal Pharma
?159.72-0.48 (0.30%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
159.21
Today’s high
162.08
52 week low
132.30
52 week high
220.85
Open price
160.40
Previous close
160.20
Live volume
31,42,398
Lower circuit
128.16
Upper circuit
192.24
Fundamentals
Market Cap
?21,328Cr
ROE
-3.58%
P/E Ratio(TTM)
--
EPS(TTM)
-2.45
P/B Ratio
2.61
Dividend Yield
0.00%
Industry P/E
33.86
Book Value
61.34
Debt to Equity
0.70
Face Value
10
Financial performance
MAR '26
Revenue (Cr)
?2,798
+28.16%
Profit (Cr)
-?8.83
+93.52%
-80001k2k3k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | 0% |
| 3Y CAGR | +11% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | -38% |
About
Piramal Pharma Limited is a global pharmaceutical company with a presence in over 100 countries. It operates through three main business segments: a) Piramal Pharma Solutions (PPS): An integrated Contract Development and Manufacturing Organization (CDMO). b) Piramal Critical Care (PCC): A complex hospital generics business focusing on inhalation anesthetics and injectables. c) India Consumer Healthcare (ICH): A retail business selling well-known over-the-counter (OTC) brands like Saridon, Lacto Calamine, and i-pill.;
CEO/MD
Mr. Peter DeYoung
Founded in
2020
NSE symbol
PPLPHARMA
Shareholding Pattern
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Mutual Funds Invested (4)
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Sai Life SciencesSAILIFE | ?1,233.00 +26.20 (2.17%) | 25,592.80 | 73.35 | 10.3 | ||
Neuland LaboratoriesNEULANDLAB | ?17,336.00 +116.00 (0.67%) | 22,082.74 | 60.67 | 11.79 | ||
Onesource Specialty PharmaONESOURCE | ?1,616.90 -34.30 (2.08%) | 18,922.29 | 1047.74 | 3.24 | ||
Syngene InternationalSYNGENE | ?440.15 -0.15 (0.03%) | 17,777.59 | 56.1 | 3.67 |
Livesquawk ?
Piramal Pharma saw an NSE block trade of ~3.52M shares at Rs. 168.22.
The trade was worth Rs. 59.1 crore, reflecting significant investor activity.
Livesquawk ?
Piramal Pharma to avoid GLP-1 competition, focus on unique peptides.
Company aims to build dedicated market positions for its peptide products.
Livesquawk ?
Piramal Pharma's Dahej facility resumes normal operations as GPCB lifts closure orders.
The company emphasizes continued focus on environmental compliance at the facility.
2026
28
Apr
Quarterly & Annual Result
Release date
28
Jan
Quarterly Result
Release date
2025
5
Nov
Quarterly Result
Release date
28
Jul
Quarterly Result
Release date
16JulDividendEx date?0.14per share
16
Jul
Dividend
Ex date
?0.14
per share
For each share you hold, you will receive ?0.14
Dividend amount?0.14 per share
Dividend TypeFinal
Ex Date16 Jul ‘25
Record Date16 Jul ‘25
Announcement date14 May ‘25
14MayDividendAnnounced?0.14per share
14
May
Dividend
Announced
?0.14
per share
For each share you hold, you will receive ?0.14
Dividend amount?0.14 per share
Dividend TypeFinal
Ex Date16 Jul ‘25
Record Date16 Jul ‘25
Announcement date14 May ‘25
2024
12JulDividendEx date?0.11per share
12
Jul
Dividend
Ex date
?0.11
per share
For each share you hold, you will receive ?0.11
Dividend amount?0.11 per share
Dividend TypeFinal
Ex Date12 Jul ‘24
Record Date12 Jul ‘24
Announcement date10 May ‘24
Events calendar
View upcoming events in other stocks